JFJonathan Franke

Jonathan Franke

*This is an algorithmically generated author record based on publicly available information.

Jonathan Franke has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cellular protein delivery through membrane potential driven water pores

    by Jonathan Franke, Palina Dubatouka, Amin Yourdkhani, Sahil Soni, Tillmann Utesch, Juliana Serrano, Tolga Soykan, Martin Lehmann, Han Sun, Jan Vincent V. Arafiles, et al.

    Providing immediate access for functional proteins inside living cells would unlock unprecedented control over cellular processes; however, commonly used endocytic delivery suffers from endosomal trapping and degradation. One of the most powerful non-endosomal delivery methods uses cell surface anchored cell penetrating peptide (CPP)-additives that allow proteins to enter cells directly. Nevertheless, the underlying molecular mechanism involved in direct entry via crossing the cell membrane (protein translocation through the cell) and the major driving forces remain controversially discussed. Here, we provide a stepwise molecular picture on how CPP-additives enable uptake of protein cargoes through direct membrane translocation. CPP-additives accumulate on the cell surface in nucleation zones, locally hyperpolarizing the membrane, and induce transient water pores that allow selective CPP-protein entry without compromising membrane integrity. These fundamental mechanistic insights provide a firm basis for rationally optimizing delivery strategies using highly cationic CPPs, ultimately resulting in innovative and smart protein delivery strategies to advance therapeutic protein applications. Abstract Figure:


  • Open Access

    Intracellular Delivery of Native Proteins by BioReversible Arginine Modification (BioRAM) on Amino Groups

    by Jonathan Franke, Jan Vincent V. Arafiles, Christian Leis, Christian P. R. Hackenberger

    Protein‐based tools are emerging as innovative solutions to interfere with biological pathways in molecular biology and medicine. They offer advantages over traditional small molecules due to their adaptable structural diversity and their ability to engage previously inaccessible cellular targets. However, most proteins do not penetrate the lipid bilayer of mammalian cells and are therefore restricted to extracellular targets. Despite recent advances, a general method for the delivery of functional proteins into human cells remains a significant challenge. In this study, we present a bioreversible protein modification strategy of amines using short arginine‐containing peptides (termed BioRAM) that enables cytosolic delivery starting from genetically non‐engineered proteins. We optimized the bioconjugation strategy to achieve fast intracellular cleavage and complete recovery of the native protein. In combination with our previously established cell‐penetrating peptide (CPP)‐additive protocol, we show superior delivery of fluorescent protein and functional RNase A into the cytosol, achieving physiological response. Moreover, we are able to demonstrate the excellent performance of BioRAM in the presence of serum, thereby broadening the scope for intracellular applications of functional proteins.


  • Open Access

    Intrazellulärer Transport nativer Proteine durch Bioreversible Arginin‐Modifikation (BioRAM) primärer Aminogruppen

    by Jonathan Franke, Jan Vincent V. Arafiles, Christian Leis, Christian P. R. Hackenberger

    Zusammenfassung: Proteinbasierte Werkzeuge gewinnen zunehmend an Bedeutung als innovative Ansätze zur gezielten Beeinflussung biologischer Signalwege in der Molekularbiologie und Medizin. Im Vergleich zu klassischen niedermolekularen Wirkstoffen bieten sie Vorteile durch ihre strukturelle Diversität und die Fähigkeit, bislang schwer zugängliche zelluläre Zielstrukturen zu adressieren. Allerdings durchdringen die meisten Proteine die Lipiddoppelschicht von Säugerzellen nicht und sind daher auf extrazelluläre Strukturen beschränkt. Trotz jüngster Fortschritte stellt der intrazelluläre Transport funktioneller Proteine in humane Zellen weiterhin eine erhebliche Herausforderung dar. In der vorliegenden Studie präsentieren wir eine bioreversible Modifikationsstrategie primärer Amine mithilfe kurzer, Arginin‐haltiger Peptide (bezeichnet als BioRAM), welche die zytosolische Aufnahme genetisch nicht veränderter Proteine ermöglicht. Die Biokonjugationsstrategie wurde dahingehend optimiert, eine schnelle intrazelluläre Abspaltung und vollständige Wiederherstellung der nativen Proteinfunktion zu gewährleisten. In Kombination mit unserem zuvor etablierten zellpenetrierenden Peptid‐Additivprotokoll demonstrieren wir einen effizienten intrazellulären Transport von fluoreszierenden Proteinen und funktioneller RNase A, die in der Zelle zu physiologisch relevanten Effekten führen. Darüber hinaus zeigen wir die hohe Leistungsfähigkeit von BioRAM auch in Anwesenheit von Serum, was das Anwendungsspektrum funktioneller Proteine im intrazellulären Kontext deutlich erweitert.

  • Open Access

    Alternative Benzoxazole Assembly Discovered in Anaerobic Bacteria Provides Access to Privileged Heterocyclic Scaffold

    by Therese Horch, Evelyn M. Molloy, Florian Bredy, Veit G. Haensch, Kirstin Scherlach, Kyle L. Dunbar, Jonathan Franke, Christian Hertweck

    Benzoxazole scaffolds feature prominently in diverse synthetic and natural product‐derived pharmaceuticals. Our understanding of their bacterial biosynthesis is, however, limited to ortho‐substituted heterocycles from actinomycetes. We report an overlooked biosynthetic pathway in anaerobic bacteria (typified in Clostridium cavendishii) that expands the benzoxazole chemical space to meta‐substituted heterocycles and heralds a distribution beyond Actinobacteria. The first benzoxazoles from the anaerobic realm (closoxazole A and B) were elucidated by NMR and chemical synthesis. By genome editing in the native producer, heterologous expression in Escherichia coli, and systematic pathway dissection we show that closoxazole biosynthesis invokes an unprecedented precursor usage (3‐amino‐4‐hydroxybenzoate) and manner of assembly. Synthetic utility was demonstrated by the precursor‐directed biosynthesis of a tafamidis analogue. A bioinformatic survey reveals the pervasiveness of related gene clusters in diverse bacterial phyla.


  • Open Access

    Alternative Benzoxazole Assembly Discovered in Anaerobic Bacteria Provides Access to Privileged Heterocyclic Scaffold

    by Therese Horch, Evelyn M. Molloy, Florian Bredy, Veit G. Haensch, Kirstin Scherlach, Kyle L. Dunbar, Jonathan Franke, Christian Hertweck

    Benzoxazole scaffolds feature prominently in diverse synthetic and natural product‐derived pharmaceuticals. Our understanding of their bacterial biosynthesis is, however, limited to ortho‐substituted heterocycles from actinomycetes. We report an overlooked biosynthetic pathway in anaerobic bacteria (typified in Clostridium cavendishii) that expands the benzoxazole chemical space to meta‐substituted heterocycles and heralds a distribution beyond Actinobacteria. The first benzoxazoles from the anaerobic realm (closoxazole A and B) were elucidated by NMR and chemical synthesis. By genome editing in the native producer, heterologous expression in Escherichia coli, and systematic pathway dissection we show that closoxazole biosynthesis invokes an unprecedented precursor usage (3‐amino‐4‐hydroxybenzoate) and manner of assembly. Synthetic utility was demonstrated by the precursor‐directed biosynthesis of a tafamidis analogue. A bioinformatic survey reveals the pervasiveness of related gene clusters in diverse bacterial phyla.